Suppr超能文献

结节性硬化症患者的治疗模式与资源利用:来自TOSCA注册研究的见解

Treatment Patterns and Use of Resources in Patients With Tuberous Sclerosis Complex: Insights From the TOSCA Registry.

作者信息

Marques Ruben, Belousova Elena, Benedik Mirjana P, Carter Tom, Cottin Vincent, Curatolo Paolo, Dahlin Maria, D'Amato Lisa, Beaure d'Augères Guillaume, de Vries Petrus J, Ferreira José C, Feucht Martha, Fladrowski Carla, Hertzberg Christoph, Jozwiak Sergiusz, Lawson John A, Macaya Alfons, Nabbout Rima, O'Callaghan Finbar, Qin Jiong, Sander Valentin, Sauter Matthias, Shah Seema, Takahashi Yukitoshi, Touraine Renaud, Youroukos Sotiris, Zonnenberg Bernard, Kingswood John C, Jansen Anna C

机构信息

Novartis Farma SpA, Origgio, Italy.

Institute of Biomedicine (IBIOMED), University of Leon, León, Spain.

出版信息

Front Neurol. 2019 Oct 25;10:1144. doi: 10.3389/fneur.2019.01144. eCollection 2019.

Abstract

Tuberous Sclerosis Complex (TSC) is a rare autosomal-dominant disorder caused by mutations in the or genes. Patients with TSC may suffer from a wide range of clinical manifestations; however, the burden of TSC and its impact on healthcare resources needed for its management remain unknown. Besides, the use of resources might vary across countries depending on the country-specific clinical practice. The aim of this paper is to describe the use of TSC-related resources and treatment patterns within the TOSCA registry. A total of 2,214 patients with TSC from 31 countries were enrolled and had a follow-up of up to 5 years. A search was conducted to identify the variables containing both medical and non-medical resource use information within TOSCA. This search was performed both at the level of the core project as well as at the level of the research projects on epilepsy, subependymal giant cell astrocytoma (SEGA), lymphangioleiomyomatosis (LAM), and renal angiomyolipoma (rAML) taking into account the timepoints of the study, age groups, and countries. Data from the quality of life (QoL) research project were analyzed by type of visit and age at enrollment. Treatments varied greatly depending on the clinical manifestation, timepoint in the study, and age groups. GAB Aergics were the most prescribed drugs for epilepsy, and mTOR inhibitors are dramatically replacing surgery in patients with SEGA, despite current recommendations proposing both treatment options. mTOR inhibitors are also becoming common treatments in rAML and LAM patients. Forty-two out of the 143 patients (29.4%) who participated in the QoL research project reported inpatient stays over the last year. Data from non-medical resource use showed the critical impact of TSC on job status and capacity. Disability allowances were more common in children than adults (51.1% vs 38.2%). Psychological counseling, social services and social worker services were needed by <15% of the patients, regardless of age. The long-term nature, together with the variability in its clinical manifestations, makes TSC a complex and resource-demanding disease. The present study shows a comprehensive picture of the resource use implications of TSC.

摘要

结节性硬化症(TSC)是一种罕见的常染色体显性疾病,由TSC1或TSC2基因的突变引起。TSC患者可能会出现广泛的临床表现;然而,TSC的负担及其对管理所需医疗资源的影响仍然未知。此外,资源的使用可能因国家而异,这取决于各国特定的临床实践。本文的目的是描述TOSCA注册中心内TSC相关资源的使用情况和治疗模式。共有来自31个国家的2214名TSC患者入组,并进行了长达5年的随访。在TOSCA中进行了一项搜索,以识别包含医疗和非医疗资源使用信息的变量。该搜索在核心项目层面以及癫痫、室管膜下巨细胞星形细胞瘤(SEGA)、淋巴管平滑肌瘤病(LAM)和肾血管平滑肌脂肪瘤(rAML)的研究项目层面进行,同时考虑了研究的时间点、年龄组和国家。生活质量(QoL)研究项目的数据按就诊类型和入组年龄进行分析。治疗方法因临床表现、研究中的时间点和年龄组而异。γ-氨基丁酸能药物是治疗癫痫最常用的药物,尽管目前的建议提出了两种治疗选择,但mTOR抑制剂正在显著取代SEGA患者的手术治疗。mTOR抑制剂在rAML和LAM患者中也越来越成为常用的治疗方法。参与QoL研究项目的143名患者中有42名(29.4%)报告在过去一年中有住院治疗。非医疗资源使用数据显示了TSC对工作状态和能力的重大影响。儿童领取残疾津贴的情况比成人更普遍(51.1%对38.2%)。无论年龄大小,不到15%的患者需要心理咨询、社会服务和社会工作者服务。TSC的长期性及其临床表现的变异性,使其成为一种复杂且资源需求大的疾病。本研究展示了TSC资源使用影响的全面情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ff/6823684/3d986aa04265/fneur-10-01144-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验